ClarIDHy: A phase 3 multicenter randomized double-blind study of AG-120 versus placebo in patients with non-resectable or metastatic cholangiocarcinoma with an IDH1 mutation Meeting Abstract


Authors: Abou-Alfa, G. K.; Valle, J. W.; Kelley, R. K.; Goyal, L.; Shroff, R. T.; Javle, M. M.; Borad, M. J.; Cleary, J. M.; El-Khoueiry, A. B.; Bendell, J. C.; Macarulla, T. M.; Vogel, A.; Korth, C.; Jiang, L.; Gliser, C.; Wu, B.; Agresta, S. V.; Pandya, S. S.; Zhu, A. X.
Abstract Title: ClarIDHy: A phase 3 multicenter randomized double-blind study of AG-120 versus placebo in patients with non-resectable or metastatic cholangiocarcinoma with an IDH1 mutation
Meeting Title: 2018 Gastrointestinal Cancers Symposium
Journal Title: Journal of Clinical Oncology
Volume: 36
Issue: 4 Suppl.
Meeting Dates: 2018 Jan 18-20
Meeting Location: San Francisco, CA
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2018-02-01
Language: English
ACCESSION: WOS:000436174100525
PROVIDER: wos
DOI: 10.1200/JCO.2018.36.4_suppl.TPS545
Notes: Meeting Abstract: TPS545 -- Source: Wos
Altmetric Score
MSK Authors
  1. Ghassan Abou-Alfa
    229 Abou-Alfa